Blackmores Limited  

(Public, ASX:BKL)   Watch this stock  
Find more results for ROBERT MERCADO
May 22 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range     -
52 week 26.66 - 73.55
Open     -
Vol / Avg. 0.00/26,294.00
Mkt cap 1.26B
P/E 39.79
Div/yield 0.68/2.04
EPS 1.86
Shares 17.22M
Beta     -
Inst. own     -

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 9.02% 7.33%
Operating margin 13.67% 11.47%
EBITD margin - 13.00%
Return on average assets 15.15% 10.87%
Return on average equity 33.68% 25.14%
Employees 800 -
CDP Score - -


20 Jubilee Ave
Balgowlah, NSW 2102
+61-2-99105000 (Phone)
+61-2-99105555 (Fax)

Website links


Blackmores Limited (Blackmores) is engaged in the development and marketing of health products for humans and animals, including vitamins, herbal and mineral nutritional supplements. The Company has operations in Australia, New Zealand and Asia. The Company offers products for Arthritis, Joint, Bone and Muscle; Brain Health; Children's Health; Cold, Flu and Immunity; Digestive Health; Energy; Everyday Health; Eye Health; Heart & Circulation; Men’s Health; Heart & Circulation; Men's Health; Nails, Hair & Skin; Nutritional Oils; Stress Relief; Teen Health; Weight Management, and Women’s Health. The Company’s subsidiaries are Blackmores Nominees Pty Limited, Pat Health Limited, Blackmores (Taiwan) Limited, Pure Animal Wellbeing Pty Limited and Blackmores (New Zealand) Limited, Blackmores (Singapore) Pte Limited, and among others.

Officers and directors

Marcus C. Blackmore Executive Chairman of the Board
Christine Wendy Holgate Chief Executive Officer, Managing Director, Executive Director
Age: 49
Christopher Last Chief Financial Officer, Company Secretary
Lee Richards Chief of Operations
Kerry Cunningham Managing Director - BioCeuticals
David Fenlon Managing Director, Australia & New Zealand
Richard Henfrey Director - Strategic Sourcing
Neal Mercado Director - Product Development
Peter Osborne Director - Asia
Gabriel Perera Director - Business Development